Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DR. MAES ILSE from Affligem, company number BE0860199067, closed financial year 2025 with a result of € 47,801 after tax. For that financial year DR. MAES ILSE recorded a gross margin of € 108,768 and equity of € 326,045. Compared with financial year 2024, the result moved from € 55,076 to € 47,801. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 326,045
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 47,801
▼ 13% vs 2024
Profit after tax over the fiscal year.
€ 15,968
▼ 86% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 38,118 paid out
80 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 60,959
▲ 240% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 232,103
▲ 7% vs 2024
€ 49,252 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 4,032
▼ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,029
▲ 56% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -623 | € 78,955 | € 123,231 | € 108,768 | ▼ 12% |
| Profit after taxes | € -12,573 | € 10,593 | € 55,076 | € 47,801 | ▼ 13% |
| Equity | € 380,959 | € 312,992 | € 316,362 | € 326,045 | ▲ 3% |
| Total debts | € 930,432 | € 252,388 | € 225,756 | € 240,580 | ▲ 7% |
| Cash | € 18,739 | € 41,597 | € 114,065 | € 15,968 | ▼ 86% |
| Land & buildings | € 218,788 | € 232,875 | € 226,587 | € 232,954 | ▲ 3% |
| Retained profit | € 362,359 | € 294,392 | € 297,762 | € 307,445 | ▲ 3% |
| Dividend | € 0 | € 78,561 | € 51,705 | € 38,118 | ▼ 26% |
| Bank debt | € 905,617 | € 252,388 | € 217,459 | € 232,103 | ▲ 7% |
| Balance sheet total | € 1,311,391 | € 565,379 | € 542,117 | € 566,625 | ▲ 5% |
Key figures of DR. MAES ILSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DR. MAES ILSE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DR. MAES ILSE?
What happened at DR. MAES ILSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 47,801 (▼ 13% vs 2024). filed late Source: NBB ↗
- New establishment in Affligem. KBO
- Start of the company according to the CBE. KBO
- Ilse Maes became a director. NBB
In short
From € 12,573 loss in 2022 to € 47,801 profit in 2025.
Paid € 93,569 in corporate taxes since 2022.
Best year ever: 2024, with € 55,076 profit.
Paid out € 168,385 in dividends to the owners in total.
Management
Behind DR. MAES ILSE is Ilse Maes.
Directors
According to the 2025 annual accounts
Ilse Maes
Manager
since 2003
Establishments
Establishment units
Physical locations of this company
De Kavee 5
1790 Affligem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0860.199.067
- VAT number
- BE 0860.199.067
- Registered office
- De Kavee 5, 1790 Affligem
- Names & denominations
- DR. MAES ILSE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 August 2003
- Peppol
- Active · Active since 6 Jun 2025